Cargando…

Oncogenic HER2 fusions in gastric cancer

BACKGROUND: Genetic amplification of HER2 drives tumorigenesis and cancer progression in a subset of patients with gastric cancer (GC), and treatment with trastuzumab, a humanized HER2-neutralizing antibody, improves the overall survival rate of HER2-positive patients. However, a considerable portio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, De-Hua, Tang, Lili, Dong, Hua, Dong, Zhengwei, Zhang, Lianhai, Fu, Jiangang, Su, Xinying, Zhang, Tianwei, Fu, Haihua, Han, Lu, Xie, Liang, Chen, Hao, Qian, Ziliang, Zhu, Guanshan, Wang, Jia, Ye, Qingqing, Zhang, Jingchuan, Yin, Xiaolu, Zhang, Xiaolin, Ji, Jiafu, Ji, Qunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396883/ https://www.ncbi.nlm.nih.gov/pubmed/25889497 http://dx.doi.org/10.1186/s12967-015-0476-2

Ejemplares similares

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
por: Gavine, Paul R., et al.
Publicado: (2015)

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma
por: Dong, Hua, et al.
Publicado: (2015)

Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis
por: Ye, Peng, et al.
Publicado: (2015)

Genomic and transcriptome profiling identified both human and HBV genetic variations and their interactions in Chinese hepatocellular carcinoma
por: Dong, Hua, et al.
Publicado: (2015)

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
por: Jiang, Liyan, et al.
Publicado: (2017)

Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity
por: Zhang, Tianwei, et al.
Publicado: (2015)

Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients
por: Yin, Xiaolu, et al.
Publicado: (2015)

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
por: Wu, Xianhua, et al.
Publicado: (2012)

Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
por: Zhang, Xu-chao, et al.
Publicado: (2013)

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection
por: Wang, Xiaohong, et al.
Publicado: (2017)

Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer
por: Cui, Shaohua, et al.
Publicado: (2017)

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway
por: Fu, Runjia, et al.
Publicado: (2019)

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere
por: Li, Jing, et al.
Publicado: (2013)

Development of Serous Ovarian Cancer is Associated with the Expression of Homologous Recombination Pathway Proteins
por: Ye, Qingqing, et al.
Publicado: (2014)

A panel of DNA methylated markers predicts metastasis of pN(0)M(0) gastric carcinoma: a prospective cohort study
por: Liu, Zhaojun, et al.
Publicado: (2019)

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
por: Li, Ziyu, et al.
Publicado: (2020)

A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients
por: Zheng, Zhixue, et al.
Publicado: (2016)

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
por: Liu, Xiaoqing, et al.
Publicado: (2013)

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies
por: Platt, Adam, et al.
Publicado: (2015)

Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization
por: Yang, Min, et al.
Publicado: (2014)

Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models
por: Chen, Hao, et al.
Publicado: (2015)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

SLC3A2, antigen of mAb 3G9, promotes migration and invasion by upregulating of mucins in gastric cancer
por: Wang, Shanshan, et al.
Publicado: (2017)

Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation
por: Zhang, Wei, et al.
Publicado: (2022)

Mutant HER2 needs mutant HER3 to be an effective oncogene
por: Trenker, Raphael, et al.
Publicado: (2021)

PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
por: Xing, Xiaofang, et al.
Publicado: (2014)

Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas
por: Tang, Daoqiang, et al.
Publicado: (2014)

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2021)

Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis
por: Li, Ziyu, et al.
Publicado: (2017)

DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance
por: Wang, Xiaohong, et al.
Publicado: (2022)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Monoclonal antibody 3H11 chimeric antigen receptors enhance T cell effector function and exhibit efficacy against gastric cancer
por: Han, Haibo, et al.
Publicado: (2018)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
por: Yuan, Peng, et al.
Publicado: (2019)

Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
por: Li, Ziyu, et al.
Publicado: (2018)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study
por: Li, Ziyu, et al.
Publicado: (2018)

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells
por: Hua, Jun, et al.
Publicado: (2021)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
por: Yang, Yang, et al.
Publicado: (2021)

TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer
por: Zhang, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l5cte53mffvg2i0cv381i4miqa